Testing new medications for alcohol dependence and related pain issues.
Official title: PRECLINICAL MEDICATIONS SCREENING IN DEPENDENCE, AFFECT AND PAIN MODELS OF ALCOHOLISM
Funded at Lsu Health Sciences Center · NIH-11218407 · Data updated 2026-11-12
This study is looking at new medications that might help people dealing with alcohol dependence and the emotional and pain issues that often come with it, so that one day, there could be better treatment options for those who need them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | September 27, 2023 |
| Project end | September 26, 2025 |
| Funding year | 2024 |
| Award (this year) | $240,999 |
| NIH project number | 75N94023C00014-P00001-9999-2 |
| Project ID | NIH-11218407 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals experiencing alcohol dependence, particularly those who also face emotional or pain-related issues.
✕Less likely to help
Patients who do not have alcohol dependence or related emotional and pain challenges may not benefit from this research.
What this research studies
This research focuses on screening potential medications that could help individuals struggling with alcohol dependence and associated emotional and pain-related challenges. Using preclinical models, the study evaluates how these medications affect behavior and physiological responses related to alcohol use and pain. Patients may benefit from insights gained about effective treatments for alcoholism and its related conditions, which could lead to improved therapeutic options in the future.
Why it matters
Potential benefit: If successful, this research could lead to new medication options that effectively treat alcohol dependence and alleviate associated pain and emotional distress.
How similar studies have gone: Other research has shown promise in using preclinical models to identify effective treatments for alcohol dependence, suggesting that this approach could yield valuable insights.
Where this research is happening
-
Lsu Health Sciences Center
New Orleans, United States Active
Researchers
- Principal investigator: Edwards, Scott — Lsu Health Sciences Center
- Study coordinator: Edwards, Scott
Related research
Other NIH-funded projects on the same topics.
-
How a brain receptor links heavy drinking and depression
This work tests whether blocking a brain receptor called NK1R can reduce stress-driven heavy drinking and depressive symptoms in people with both alcohol problems and depression.
-
Genes, brains, and life: understanding alcoholism through family-based genetics
A large study of families explores how genes, brain biology, and life experiences interact to shape alcohol use, recovery, and relapse across the lifespan.
-
How the brain's immune system affects alcoholism
This project looks at how brain immune and inflammation systems contribute to heavy drinking and aims to find new treatment targets for people with alcohol use disorder.
-
Family genetics of alcohol use disorder
This project looks at how genes, brain function, and life circumstances shape alcohol problems, recovery, and relapse in people from large families, with a new focus on those aged 40 and older.
-
Mavoglurant's effects on brain reward and impulsivity in people with inherited risk for alcoholism
This project gives mavoglurant and uses brain scans during reward and impulse-control tasks to see differences between people with and without a family history of alcoholism.
-
Center developing brain-based treatments for alcohol use and addiction
This project is trying a medication that targets the brain receptor mGluR5 to reduce heavy drinking and fix brain-circuit problems linked to alcoholism.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.